Drug intelligence / Profile preview

Fufang Bufei Decoction

Development stage: Unknown
Lead developer: Sichuan University
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Fufang Bufei Decoction (FFBF) is a traditional Chinese medicine (TCM) herbal formula being evaluated for the management of postoperative cough and airway recovery in patients undergoing lung cancer surgery. In clinical studies conducted at the West China Hospital of Sichuan University, the decoction has demonstrated the potential to provide early symptomatic relief of postoperative cough on the day of discharge and reduce hospitalization costs following thoracic surgery.

Other names: FFBF decoctionFuFang-BuFei decoction

Targets

IL-6 (Interleukin 6)JAK1 (Janus kinase 1)NFKB1 (NF-κB1)STAT3 (Signal Transducer and Activator of Transcription 3)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on Fufang Bufei Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fufang Bufei Decoction.